Tofacitinib Suppresses Natural Killer Cells In Vitro and In Vivo: Implications for Amyotrophic Lateral Sclerosis is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0.520. It has been cited 31 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →ATSDR CDC HHS
Grant: R01 TS000289
NIEHS NIH HHS
Grant: R01 ES030049
NIEHS NIH HHS
Grant: K23 ES027221
NINDS NIH HHS
Grant: R01 NS120926
NINDS NIH HHS
Grant: R21 NS102960
National Institutes of Health
Grant: 1R01TS000289-01
Metabolomic Signatures Linking ALS to Persistent Organic Pollutant Exposures
National Institutes of Health
Grant: 5T32NS007222-27
Training in Clinical and Basic Neuroscience
National Institutes of Health
Grant: 5K23ES027221-03
Impact of Geospatial Factors and Environmental Pollutants on Amyotrophic Lateral Sclerosis in the State of Michigan
National Institutes of Health
Grant: 1R21NS102960-01A1
The Role of NK Cells in ALS
National Institutes of Health
Grant: 3R01ES030049-02S1
Mapping the ALS Exposome to Gain New Insights into Disease Risk and Pathogenesis
FWCI
1.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals